Platform introducing individually tailored variability in nerve stimulations and dietary regimen to prevent weight regain following weight loss in patients with obesity-Reference-Cited by-同舟云学术

Platform introducing individually tailored variability in nerve stimulations and dietary regimen to prevent weight regain following weight loss in patients with obesity

Published:2021-03 Issue:2 Volume:15 Page:114-123
ISSN:1871-403X
Container-title:Obesity Research & Clinical Practice
language:en
Short-container-title:Obesity Research & Clinical Practice

Author:

Khoury Tawfik,Ilan Yaron^ORCID

Publisher

Elsevier BV

Subject

Nutrition and Dietetics,Endocrinology, Diabetes and Metabolism

Reference156 articles.

1. Usefulness of combining intermittent hypoxia and physical exercise in the treatment of obesity;Urdampilleta;J Physiol Biochem,2012

2. Mechanisms of weight regain after weight loss — the role of adipose tissue;van Baak;Nat Rev Endocrinol,2019

3. Long-term persistence of hormonal adaptations to weight loss;Sumithran;N Engl J Med,2011

4. A Brief Behavioural Intervention to Promote Regular Self-Weighing to Prevent Weight Regain After Weight Loss: a RCT. Southampton (UK);Daley,2019

5. Controversial issues: a practical guide to the use of weight loss medications after bariatric surgery for weight regain or inadequate weight loss;Stanford;Surg Obes Relat Dis,2019

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Overcoming Low Adherence to Chronic Medications by Improving their Effectiveness using a Personalized Second-generation Digital System;Current Pharmaceutical Biotechnology;2024-12

2. Improving the response to lenvatinib in partial responders using a Constrained-Disorder-Principle-based second-generation artificial intelligence-therapeutic regimen: a proof-of-concept open-labeled clinical trial;Frontiers in Oncology;2024-07-30

3. Free Will as Defined by the Constrained Disorder Principle: a Restricted, Mandatory, Personalized, Regulated Process for Decision-Making;Integrative Psychological and Behavioral Science;2024-06-20

4. A Feasibility Open-Labeled Clinical Trial Using a Second-Generation Artificial-Intelligence-Based Therapeutic Regimen in Patients with Gaucher Disease Treated with Enzyme Replacement Therapy;Journal of Clinical Medicine;2024-06-05

5. The Constrained Disorder Principle May Account for Consciousness;Brain Sciences;2024-02-23